发明名称 |
Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen |
摘要 |
The invention relates to a universal tumour-associated oligopeptide, which is recognised by CD8-positive cytotoxic T-lymphocytes (CTL) as a peptide antigen and which causes a CTL-induced lysis and/or apoptosis of tumour or leukaemia cells. The oligopeptide has the amino acid sequence LLGDLFGV, which corresponds to the amino acid positions 81 to 88 of the hdm2 proto-oncoprotein, or an amino acid sequence that can be derived from said sequence, which constitutes the functional equivalent of the amino acid sequence LLGDLFGV. Said oligopeptide constitutes an epitope for CD8-positive CTLs and is suitable for inducing a restricted immune response of CD8-positive CTLs to the human leukocyte antigen of the molecular group MHC class I, allelomorph variant A2, against tumour and leukaemia cells.
|
申请公布号 |
DE10109813(A1) |
申请公布日期 |
2002.09.12 |
申请号 |
DE20011009813 |
申请日期 |
2001.03.01 |
申请人 |
STANISLAWSKI, THOMAS;THEOBALD, MATTHIAS |
发明人 |
STANISLAWSKI, THOMAS;THEOBALD, MATTHIAS |
分类号 |
G01N33/50;A61K31/7088;A61K38/00;A61K39/00;A61K48/00;A61P35/00;A61P35/02;A61P43/00;C07K7/06;C07K14/47;C07K14/705;C07K16/32;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12N15/12;C12P21/08;C12Q1/68;(IPC1-7):C07K7/06 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|